DNA damage targets PKCη to the nuclear membrane via its C1b domain

Experimental Cell Research

Volumn 317, Issue 10, 2011, Pages 1465-1475

  Tamarkin, Ana ^a   Zurgil, Udi ^a   Braiman, Alex ^a   Hai, Naama ^a   Krasnitsky, Ella ^a   Maissel, Adva ^a   Ben Ari, Assaf ^a   Yankelovich, Liat ^a   Livneh, Etta ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cell death; Etoposide; Nuclear envelope; PKC

Indexed keywords

DNA; ETOPOSIDE; PROTEIN KINASE C ETA;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL FUNCTION; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELL PROTECTION; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; ENDOPLASMIC RETICULUM; FEMALE; GOLGI COMPLEX; HUMAN; HUMAN CELL; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

EID: 79955961097     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.03.021     Document Type: Article

References (45)

1. Rosse C., Linch M., Kermorgant S., Cameron A.J., Boeckeler K., P.P.J. PKC and the control of localized signal dynamics. Nat. Rev. Mol. Cell Biol. 2010, 11:103-112.
2. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995, 9:484-496.
3. Mellor H., Parker P.J. The extended protein kinase C superfamily. Biochem. J. 1998, 332:281-292.
4. Leitges M. Functional PKC in vivo analysis using deficient mouse models. Biochem. Soc. Trans. 2007, 35:1018-1020.
5. Newton A.C. Protein kinase C: structure and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 2001, 101:2353-2364.
6. Newton A.C. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem. J. 2003, 370:361-371.
7. Borner C., Filipuzzi I., Wartmann M., Eppenberger U., Fabbro D. Biosynthesis and posttranslational modifications of protein kinase C in human breast cancer cells. J. Biol. Chem. 1989, 264:13902-13909.
8. Dempsey E.C., Newton A.C., Mochly-Rosen D., Fields A.P., Reyland M.E., Insel P.A., Messing R.O. Protein kinase C isozymes and the regulation of diverse cell responses. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L429-L438.
9. Griner E.M., Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 2007, 7:281-294.
10. Giorgione J.R., Lin J.H., McCammon J.A., Newton A.C. Increased membrane affinity of the C1 domain of protein kinase Cdelta compensates for the lack of involvement of its C2 domain in membrane recruitment. J. Biol. Chem. 2006, 281:1660-1669.
11. Schaefer M., Albrecht N., Hofmann T., Gudermann T., Schultz G. Diffusion-limited translocation mechanism of protein kinase C isotypes. FASEB J. 2001, 15:1634-1636.
12. Bacher N., Zisman Y., Berent E., Livneh E. Isolation and characterization of PKC-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin, and heart. Mol. Cell. Biol. 1991, 11:126-133.
13. Ohba M., Ishino K., Kashiwagi M., Kawabe S., Chida K., Huh N., Kuroki T. Induction of differentiation in normal human keratinocytes by adenovirus-mediated induction of η and δ isoforms of protein kinase C. Mol. Cell. Biol. 1998, 18:5199-5207.
14. Livneh E., Shimon T., Bechor E., Doki Y., Schieren I., Weinstein I.B. Linking protein kinase C to the cell cycle: ectopic expression of PKCη in NIH-3T3 cells alters the expression of cyclins and Cdk inhibitors and induces adipogenesis. Oncogene 1996, 12:1545-1555.
15. Hussaini I.M., Karns L.R., Vinton G., Carpenter J.E., Redpath G.T., Sando J.J., Vandenberg S.R. Phorbol 12-myristate 13-acetate induces protein kinase Cη-specific proliferative response in astrocytic tumor cells. J. Biol. Chem. 2000, 275:22348-22354.
16. Fima E., Shtutman M., Libros P., Missel A., Shahaf G., Kahana G., Livneh E. PKCη enhanced cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells. Oncogene 2001, 20:6794-6804.
17. Livneh E., Fishman D.D. Linking protein kinase C to cell cycle control. Eur. J. Biochem. 1997, 248:1-9.
18. Shtutman M., Hershko T., Maissel A., Fima E., Livneh E. PKCη associates with cyclin E/Cdk2 complex in serum-starved MCF-7 and NIH-3T3 cells. Exp. Cell Res. 2003, 286:22-29.
19. Kashiwagi M., Ohba M., Watanabe H., Ishino K., Kasahara K., Sanai Y., Taya Y., Kuroki T. PKCη associates with cyclin E/Cdk2/p21 complex, phosphorylates p21 and inhibits Cdk2 kinase in keratinocytes. Oncogene 2000, 19:6334-6341.
20. Basu A. The involvement of novel protein kinase C isoenzymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha. Mol. Pharmacol. 1998, 53:105-111.
21. Akkaraju G.R., Basu A. Overexpression of protein kinase C-η attenuates caspase activation and tumor necrosis factor η-induced cell death. Biochem. Biophys. Res. Commun. 2000, 279:103-107.
22. Hussaini I.M., Carpenter J.E., Redpath G.T., Sando J.J., Shaffrey M.E., VandenBerg S.R. Protein kinase C-γ regulates resistance to UV and η-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation. Neuro Oncol. 2002, 4:9-21.
23. Matsumura M., Tanaka N., Kuroli T., Ichihashi M., Ohba M. The η isoform of protein kinase C inhibits UV-induced activation of caspase 3 in normal human keratinocytes. Biochem. Biophys. Res. Commun. 2003, 303:350-356.
24. Sonnemann J., Gekeler V., Sagrauske A., Muller C., Hofmann H.P., Beck J.F. Down-regulation of PKCη potentiates the cytotoxic effects of exogenous tumor necrosis factor-related apoptosis-inducing ligand in PC-3 prostate cancer cells. Mol. Cancer Ther. 2004, 3:773-781.
25. Rotem-Dai N., Oberkovitz G., Abu-Ghanem S., Livneh E. PKCeta confers protection against apoptosis by inhibiting the pro-apoptotic JNK activity in MCF-7 cells. Exp. Cell Res. 2009, 315:2616-2623.
26. Abu-Ghanem S., Oberkovitz G., Benharroch D., Gopas J., Livneh E. PKCη expression contributes to the resistance of Hodgkin's lymphoma cell lines to apoptosis. Cancer Biol. Ther. 2007, 6:1375-1380.
27. Beck J., Bohnet B., Brugger D., Bader P., Dietl J., Scheper R.J., Kandolf R., Liu C., Niethammer D., Gekeler V. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKCη with MDR1, MRP and LRP gene expression. Br. J. Cancer 1998, 77:87-91.
28. Beck J.F., Bohnet B., Brugger B., Dietel J., Scheper R.J. Expression analysis of protein kinase C isoenzymes and multidrug resistance associated genes in ovarian cancer cells. Anticancer Res. 1998, 18:701-705.
29. Beck J.F., Handgretinger R., Klingebiel T., Dopfer R., Schaich M., Ehninger G. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. Leukemia 1996, 10:426-433.
30. Sonnemann J., Gekeler V., Ahlbresht K., Brischwein K., Liu C., Bader P., Muller C., Niethammer D., Beck J.F. Down-regulation of protein kinase Cη by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel. Cancer Lett. 2004, 209:177-185.
31. Maissel A., Marom M., Shtutman M., Shahaf G., Livneh E. PKCη is localizes in the Golgi, ER and nuclear envelope and translocates to the nuclear envelope upon PMA activation and serum-starvation: C1b domain and the pseudosubstrate containing fragment target PKCη to the Golgi and the nuclear envelope. Cell. Signal. 2006, 18:1127-1139.
32. Eldar H., Ben-Chaim J., Livneh E. Deletions in the regulatory or kinase domains of protein kinase C-α cause association with the cell nucleus. Exp. Cell Res. 1992, 202:259-266.
33. Yoshida M., Horinouchi S. Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export. Ann. N. Y. Acad. Sci. 1999, 886:23-36.
34. Herceg Z., Wang Z.Q. Functions of poly ADP-ribose polymerase (PARP) in DNA repair, genomic instability and cell death. Mutat. Res. 2001, 477:97-110.
35. Soldani C., Scovassi A.I. Poly (ADP-ribose) polymerase I cleavage during apoptosis: an update. Apoptosis 2002, 7:321-328.
36. Redon C., Pilch D., Rogakou E., Sedelnikova O., Newrock K., Bonner W. Histone H2A variants H2AX and H2AZ. Curr. Opin. Genet. Dev. 2002, 12:162-169.
37. Meresse P., Dechaux E., Monneret C., Bertounesque E. Etoposide: discovery and medicinal chemistry. Curr. Med. Chem. 2004, 11:2443-2466.
38. Chiarini A., Whitfield J.F., Armato U., Dal Pra I. VP-16 (etoposide) and calphostin C trigger different nuclear but akin cytoplasmic patterns of changes in the distribution and activity of protein kinase C-betaI in polyomavirus-transformed pyF111 rat fibroblasts. Int. J. Mol. Med. 2006, 17:111-120.
39. Chida K., Sagara H., Suzuki Y., Murakami A., Osada S., Ohno S., Hirosawa K., Kuroki T. The eta isoform of protein kinase C is localized on rough endoplasmic reticulum. Mol. Cell. Biol. 1994, 14:3782-3790.
40. Dries D.R., Gallegos L.L., Newton A.C. A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production. J. Biol. Chem. 2007, 282:826-830.
41. Colon-Gonzalez F., Kazanietz M.G. C1 domains exposed: from diacylglycerol binding to protein-protein interactions. Biochim. Biophys. Acta 2006, 1761:827-837.
42. Yoshida K. Nuclear trafficking of pro-apoptotic kinases in response to DNA damage. Trends Mol. Med. 2008, 14:305-313.
43. DeVries-Seimon T.A., Ohm A.M., Humphries M.J., Reyland M.E. Induction of apoptosis is driven by nuclear retention of protein kinase C delta. J. Biol. Chem. 2007, 282:22307-22314.
44. Gomel R., Xiang C., Finniss S., Lee H.K., Lu W., Okhrimenko H., Brodie C. The localization of protein kinase Cdelta in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways. Mol. Cancer Res. 2007, 5:627-639.
45. Cross T.G., Scheel-Toellner D., Henriquez N.V., Deacon E., Salmon M., Lord J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 2000, 256:34-41.